-
Modeling the Environmental and Cost Impact of a Novel Detergent in NHS Endoscope Reprocessing Workflows
Sep 9, 2025, 16:22 PM -
Real-World Evidence on Treatment Patterns and Guidelines in Patients With Advanced Merkel Cell Carcinoma Across the US and Europe
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Pegcetacoplan for the Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients With Treatment Failure After C5 Inhibitor Therapy: An Analysis From the Brazilian Public Healthcare System Perspective
Sep 9, 2025, 16:22 PM -
Direct Medical Costs of Home-Based Respiratory Support and Oxygen Therapy for Patients With Chronic Respiratory Failure
Sep 9, 2025, 16:22 PM -
Inpatient Cost of Managing Adverse Events (AEs) Associated With Immune Checkpoint Inhibitors (ICI) Approved for Advanced or Metastatic Cancers in the UK
Sep 9, 2025, 16:22 PM -
The EB Insights Study: The Impact of Epidermolysis Bullosa on Carer Health-Related Quality of Life
Sep 9, 2025, 16:22 PM -
Applying the Evidence-Generation Continuum Concept to Support Patient Access to Innovative Therapies in France: A Use Case in Rare Diseases
Sep 9, 2025, 16:22 PM -
Which Country Is Currently Reporting the Lowest Global Prices for Semaglutide, and Why?
Sep 9, 2025, 16:22 PM -
Empirical Comparison of Four Approaches for Generating Confidence Intervals Around Weighted Trial-Level Correlation
Sep 9, 2025, 16:22 PM -
Investigation of the Impact of Hereditary Angioedema (HAE) on Health-Related Quality of Life: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Rescaled Tariff Regression for EQ-5D-5L Health State Valuation: An Equivalent Alternative to the Nonparametric Crosswalk
Sep 9, 2025, 16:22 PM -
A Comparative Analysis of the Nordic Market Access Pathways for Medical Devices
Sep 9, 2025, 16:22 PM -
Mapping of Treatment Patterns and Transfusion Status in Danish and Swedish Myelofibrosis (MF) Patients
Sep 9, 2025, 16:22 PM -
Optimizing Healthcare Access Through Policy Innovation: An Implementation Evaluation Framework for Hepatitis C Elimination Program in Malaysia
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Pegunigalsidase Alfa Compared to Agalsidase Alfa and Agalsidase Beta for the Treatment of Adult Patients With Fabry Disease in Greece
Sep 9, 2025, 16:22 PM -
Analysis of the Fiscal and Socioeconomic Impact of a National Social Program to Support In Vitro Fertilization in Romania: A Generational Accounting Model
Sep 9, 2025, 16:22 PM -
Evaluating AI Chatbot Empathy and Probing Skills in Automated Patient In-Trial Interviews: A Proof of Principle Experiment
Sep 9, 2025, 16:22 PM -
AI-Enabled Wearables for Fitness and Preventive Health
Sep 9, 2025, 16:22 PM -
A Gap Analysis of HTA Methods in Europe: Results From SUSTAIN-HTA
Sep 9, 2025, 16:22 PM -
From Evidence to Excel: Generative AI for Automated SLR Data Extractions
Sep 9, 2025, 16:22 PM
